 Pratibha Binder
|
| Title | Assistant Clinical Professor |
|---|
| Institution | University of California San Diego |
|---|
| Department | Reproductive Medicine |
|---|
| Address | 9500 Gilman Drive #0987
La Jolla CA 92093
|
|---|
| vCard | Download vCard |
|---|
|
|
 ORNG Applications Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Researchers can login to make corrections and additions, or contact us for help.
-
Binder P, Kuroki LM, Zhao P, Cusworth S, Divine LM, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Mutch DG, Massad LS. Benefit of combination chemotherapy and radiation stratified by grade of stage IIIC endometrial cancer. Gynecol Oncol. 2017 11; 147(2):309-314. PMID: 28916118.
-
Hashim YM, Vangveravong S, Sankpal NV, Binder P, Liu J, Goedegebuure SP, Mach RH, Spitzer D, Hawkins WG. The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancer. J Exp Clin Cancer Res. 2017 01 17; 36(1):14. PMID: 28095907.
-
Binder P, Massad LS, Mutch DG, Powell MA, Thaker PH, McCourt CK, Peipert JF, Kallogjeri D, Brooks RA. Reply. Am J Obstet Gynecol. 2017 02; 216(2):192-193. PMID: 27640937.
-
Binder P, Peipert JF, Kallogjeri D, Brooks RA, Massad LS, Mutch DG, Powell MA, Thaker PH, McCourt CK. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients. Am J Obstet Gynecol. 2016 Dec; 215(6):766.e1-766.e9. PMID: 27457116.
-
Su Y, Tatzel K, Wang X, Belt B, Binder P, Kuroki L, Powell MA, Mutch DG, Hawkins WG, Spitzer D. Mesothelin's minimal MUC16 binding moiety converts TR3 into a potent cancer therapeutic via hierarchical binding events at the plasma membrane. Oncotarget. 2016 May 24; 7(21):31534-49. PMID: 27120790.
-
Kuroki LM, Binder P, Powell MA, Massad LS, Gao F. Self-reported human papillomavirus vaccination does not have an impact on the risk for high-grade cervical intraepithelial neoplasia among women referred for colposcopy. Am J Obstet Gynecol. 2016 07; 215(1):123-6. PMID: 26944187.
-
Binder P, Prat J, Mutch DG. The future role of molecular staging in gynecologic cancer. Int J Gynaecol Obstet. 2015 Oct; 131 Suppl 2:S127-31. PMID: 26433669.
-
Binder P, Prat J, Mutch DG. Molecular staging of gynecological cancer: What is the future? Best Pract Res Clin Obstet Gynaecol. 2015 Aug; 29(6):776-89. PMID: 25934522; PMCID: PMC4532616.
-
Binder P, Mutch DG. Update on prognostic markers for endometrial cancer. Womens Health (Lond). 2014 May; 10(3):277-88. PMID: 24956294.
|
Concepts Derived automatically from this person's publications. _
Related Authors People who share related concepts with this person. _
|